VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
JBS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
JBSJbs N.V.
$12.10$26.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. JBS
  4. Financial Ratios

Jbs N.V. (JBS) Financial Ratios

Latest Ratios: P/E Ratio 17.2x · EV/EBITDA 10.6x · ROE 21.6%. (2014–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

JBS Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$26.8B$15.4B—————————
Enterprise Value$44.2B$116.0B—————————
P/E Ratio →17.181.39—————————
P/S Ratio0.410.03—————————
P/B Ratio1.430.29—————————
P/FCF—3.73—————————
P/OCF10.040.99—————————

P/E links to full P/E history page with 30-year chart

JBS EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.25—————————
EV / EBITDA10.583.29—————————
EV / EBIT11.324.92—————————
EV / FCF—28.10—————————

JBS Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin12.8%12.8%15.1%10.9%15.9%18.9%16.7%15.6%14.5%14.6%12.5%
Operating Margin4.8%4.8%5.7%1.5%6.6%9.2%7.6%6.6%3.9%4.1%3.9%
Net Profit Margin2.4%2.4%2.3%-0.3%4.1%5.9%1.7%3.0%0.0%0.3%0.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE21.6%21.6%19.8%-2.2%32.5%46.5%12.1%20.1%0.1%2.2%0.9%
ROA4.4%4.4%4.2%-0.5%7.6%11.4%3.2%5.0%0.0%0.5%0.2%
ROIC11.2%11.2%12.5%2.9%14.1%22.1%17.0%12.7%7.3%7.1%6.7%
ROCE12.4%12.4%14.1%3.4%16.8%24.7%18.5%14.1%8.3%9.0%8.7%

JBS Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity2.402.402.682.352.102.171.701.842.042.182.39
Debt / EBITDA3.573.573.787.042.952.442.623.024.775.095.08
Net Debt / Equity—1.921.991.881.831.681.251.531.721.731.99
Net Debt / EBITDA2.852.852.805.632.581.901.922.524.024.044.23
Debt / FCF—24.376.4722.0243.306.783.065.2210.4321.65250.62
Interest Coverage2.572.5715.603.4419.2834.515.653.242.011.492.12

JBS Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.601.601.471.641.441.401.481.471.711.241.02
Quick Ratio0.910.910.900.950.750.840.930.861.040.810.65
Cash Ratio0.410.410.480.460.240.390.480.350.410.400.28
Asset Turnover—1.901.651.761.851.751.651.621.591.501.66
Inventory Turnover9.429.428.639.838.538.669.919.9510.7111.1912.14
Days Sales Outstanding—22.7820.2516.4719.2420.0118.9119.8719.4020.8820.54

JBS Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield11.8%57.2%—————————
Payout Ratio79.4%79.4%46.1%—28.0%34.8%31.3%0.1%503.5%17.5%471.9%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield5.8%72.2%—————————
FCF Yield—26.8%—————————
Buyback Yield2.1%20.7%—————————
Total Shareholder Yield13.8%77.9%—————————
Shares Outstanding—$1.1B$2.2B$2.2B$2.3B$2.5B$2.7B$2.7B$2.7B$2.8B$2.7B

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Leverage amid thin margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q3)

Low Multiples Reflect Governance and Leverage Discount

Based on reported figures, JBS trades at a trailing P/E of 17.18 and EV/EBITDA of 10.58, which sit well below Hormel's 36.31 P/E and 17.28 EV/EBITDA, suggesting the market applies a meaningful discount to its earnings stream.

The forward P/E of 3.25 implies that the market expects a sharp earnings recovery or is pricing in a very different profit outlook than the trailing figures indicate, and this gap warrants caution. The PEG of 0.40 would appear attractive only if growth estimates are reliable, which is doubtful given the volatile EPS history. The discount relative to US-domiciled peers likely reflects governance concerns, Brazil-related risk premia, and a 2.78 debt-to-equity ratio, so investors should monitor whether the apparent cheapness persists once earnings normalize.

Margin Compression Erodes Earnings Power

According to recent SEC filings, JBS's gross margin fell from 16.5% in 2024Q3 to roughly 10.6% in 2026Q3, while operating margin compressed from 7.8% to 2.3%, indicating that cost pressure is outpacing revenue growth.

The gap between a 10.6% gross margin and a 2.3% operating margin implies that SG&A and other operating costs consume most of the gross profit, leaving little cushion against input cost swings. Net margin of 0.7% in 2026Q3 and negative in 2026Q2 suggests earnings power is currently weak on a reported basis. Adjusting for biological asset fair-value effects and non-recurring items could change the picture, and that adjustment warrants further investigation before relying on headline margins.

Returns Decaying From Earlier Peak Levels

As reported in financial statements, JBS's ROIC declined from 4.4% in 2024Q3 to 2.1% in 2026Q3, while ROE fell from 7.5% to 3.0%, pointing to a sustained erosion in returns on the capital base.

The drop in ROIC tracks the compression in operating margin more closely than any change in capital turnover, suggesting the decline is margin-driven rather than efficiency-driven. Returns at this level sit close to the company's cost of capital given its heavy debt load, which raises the question of whether recent acquisitions are generating adequate economic value. Investors should monitor whether returns recover toward prior levels or continue to decay.

Debt Load Outpacing Earnings Coverage

Based on JBS's reported figures, debt-to-equity climbed from 2.30 in 2024Q3 to 2.78 in 2026Q3, while debt-to-EBITDA reached 21.64 in the latest quarter, suggesting debt service is becoming harder to cover from current earnings.

Interest coverage swung between 0.73 and 14.39 over the period, and the most recent readings of 1.43 leave little margin for error if operating profit falls further. The combination of rising leverage and thin operating income implies reduced financial flexibility, and change-of-control provisions flagged in risk disclosures add refinancing sensitivity. The trajectory warrants monitoring of debt reduction progress and refinancing terms.

Low Forward Multiple May Mislead Valuation

The P/E ratio is most commonly misapplied to JBS, since reported earnings swing from positive to negative across recent quarters, making a single-period P/E an unreliable anchor for a commodity processor with biological asset valuation effects.

A low P/E can appear to signal value, but when earnings are depressed by commodity cycles and non-cash fair-value adjustments, the ratio may understate the true cost of the equity claim. EV/EBITDA is similarly distorted by leverage and by biological asset accounting, so normalized free cash flow yield or through-cycle margin analysis would give a more reliable read. Investors should treat the apparent cheapness as a hypothesis to test rather than a conclusion.

Download Financial Ratios Data

Includes 30+ ratios · 12 years · Updated daily

Consensus & Technical Research Suite
Open JBS Terminal

JBS Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

JBS — Frequently Asked Questions

Quick answers to the most common questions about buying JBS stock.

What is Jbs N.V.'s P/E ratio?

Jbs N.V.'s current P/E ratio is 17.2x. The historical average is 1.4x. This places it at the 100th percentile of its historical range.

What is Jbs N.V.'s EV/EBITDA?

Jbs N.V.'s current EV/EBITDA is 10.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 3.3x.

What is Jbs N.V.'s ROE?

Jbs N.V.'s return on equity (ROE) is 21.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 14.8%.

Is JBS stock overvalued?

Based on historical data, Jbs N.V. is trading at a P/E of 17.2x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Jbs N.V.'s dividend yield?

Jbs N.V.'s current dividend yield is 11.76% with a payout ratio of 79.4%.

What are Jbs N.V.'s profit margins?

Jbs N.V. has 12.8% gross margin and 4.8% operating margin.

How much debt does Jbs N.V. have?

Jbs N.V.'s Debt/EBITDA ratio is 3.6x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.